Skip to content
MedsAcross

Medicine

Neomycin Polymyxin B Sulfates and Dexamethasone 1 mg/3.5 mg/10000 units per mL ophthalmic suspension

Dexamethasone, Neomycin and Polymyxin b · Ophthalmic · Bausch & Lomb
Available on requestPrescription onlyUS FDA

Neomycin Polymyxin B Sulfates and Dexamethasone 1 mg/3.5 mg/10000 units per mL ophthalmic suspension is a prescription medicine containing Dexamethasone, Neomycin and Polymyxin b for ophthalmic use, marketed by Bausch & Lomb, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store between 15°C to 25°C (59°F to 77°F). Store upright.

Key facts

Active ingredient (INN)
Dexamethasone, Neomycin and Polymyxin b
Brand
Neomycin Polymyxin B Sulfates and Dexamethasone
Strength
1 mg/3.5 mg/10000 units per mL
Dosage form
Ophthalmic suspension
Route
Ophthalmic
Packs
1 bottle, 5 mL and 3 more
Marketing authorisation holder
Bausch & Lomb
Manufacturers
Bausch & LombA-S Medication SolutionsNuCare Pharmaceuticals,IncPreferred PharmaceuticalsProficient RxSportpharm
Origin register
US FDA, United States
Storage
Store between 15°C to 25°C (59°F to 77°F). Store upright.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
13 September 1995
Identifiers
RxCUI 309680DailyMed set ID d6d78668-a978-4cd3-bbcd-1293b5044ec9, 691bc5ca-5d61-60c2-e053-2991aa0abb93, 548089f3-29d8-4ba8-af21-9e04356ac29c +3NDC 24208-830, 68071-4375, 63187-498 +3Application ANDA064135

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper24208-830-60Bausch & Lomb13 September 1995
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper50090-0570-0A-S Medication Solutions29 June 2016
5 mL in 1 box68071-4375-5NuCare Pharmaceuticals,Inc5 April 2018
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper68788-9702-5Preferred Pharmaceuticals14 March 2013
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper63187-498-05Proficient Rx2 February 2015
1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper85766-308-05Sportpharm31 October 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 6 June 1963Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Dexamethasone, Neomycin and Polymyxin b 1 mg/3.5 mg/10000 units per mL ophthalmic suspension.

Compare all 3

Other strengths and forms of Dexamethasone, Neomycin and Polymyxin b

Clinical summary

Dexamethasone, Neomycin and Polymyxin b is a fixed-dose combination of an aminoglycoside antibacterial, a corticosteroid and a polymyxin-class antibacterial indicated and where bacterial infection or a risk of bacterial infection exists. MedsAcross supplies Dexamethasone, Neomycin and Polymyxin b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Dexamethasone, Neomycin and Polymyxin b

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Neomycin Polymyxin B Sulfates and Dexamethasone 1 mg/3.5 mg/10000 units per mL ophthalmic suspension for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.